Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
MedPage Today on MSN14h
Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly DosingA once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of ...
The Montgomery Advertiser on MSN9h
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...
A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in ...
allAfrica.com on MSN11h
South Africa: How Much Does Our HIV Response Depend On U.S. Funding?After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding.
Fiji health authorities are scrambling to stem an outbreak of HIV, as growing meth use and alarming needle-sharing trends accelerate the spread of the virus.
Sex Workers, MSM, and Transgender Persons: Disruption in access to PrEP services, reduced capacity for HIV prevention services, , reduced availability of HIV counselling and testing, and disruption in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback